Trend towards dose reduction of azathioprine as monotherapy in inflammatory bowel disease patients: what about for combination therapy?
Therap Adv Gastroenterol
.
2017 Jan;10(1):5-10.
doi: 10.1177/1756283X16670074.
Epub 2016 Oct 10.
Authors
Nicolas Williet
1
,
Xavier Roblin
2
Affiliations
1
Department of Gastroenterology, University of Saint-Etienne, France.
2
Department of Hepatogastroenterology, University Hospital of Saint-Etienne, Allee Albert Raimond, 42270 Saint-Priest en Jarez, France.
PMID:
28286554
PMCID:
PMC5330604
DOI:
10.1177/1756283X16670074
No abstract available
Publication types
Editorial